Qiagen NV (WBO:QGE2) Short-Term Capital Lease Obligation : €0 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Short-Term Capital Lease Obligation?

Qiagen NV's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0 Mil.

Qiagen NV's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€20 Mil) but then declined from Dec. 2023 (€20 Mil) to Mar. 2024 (€0 Mil).

Qiagen NV's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€20 Mil) to Dec. 2022 (€21 Mil) but then declined from Dec. 2022 (€21 Mil) to Dec. 2023 (€20 Mil).

Qiagen NV Short-Term Capital Lease Obligation Historical Data

The historical data trend for Qiagen NV's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Short-Term Capital Lease Obligation Chart

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

16.87

19.28

19.51

20.98

20.42

Qiagen NV Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	20.42	-

Qiagen NV Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Qiagen NV Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (WBO:QGE2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (WBO:QGE2) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

EXAS NTRA CRL MEDP RVTY RDNT DGX SHC NEOG GH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

QGEN:USA 1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Qiagen NV (WBO:QGE2) Headlines

No Headlines